Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile
- 1 March 2017
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 129, 27-40
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81603025, 81302636)
- Natural Science Foundation of Jiangsu Province (BK20130656)
- National Major Science and Technology Project of China (2013ZX09402102-001-005, 2014ZX09507002-005-015)
- Specialized Research Fund for the Doctoral Program of Higher Education (20130096110002)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Project Program of State Key Laboratory of Natural Medicines
- China Pharmaceutical University (SKLNMZZCX201611)
This publication has 31 references indexed in Scilit:
- Identification of Novel ROS Inducers: Quinone Derivatives Tethered to Long Hydrocarbon ChainsJournal of Medicinal Chemistry, 2015
- Synthesis of Xanthohumol Analogues and Discovery of Potent Thioredoxin Reductase Inhibitor as Potential Anticancer AgentJournal of Medicinal Chemistry, 2015
- Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damageBiochemical Pharmacology, 2014
- Bioreductively Activated Reactive Oxygen Species (ROS) Generators as MRSA InhibitorsACS Medicinal Chemistry Letters, 2014
- Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2014
- Modulation of oxidative stress as an anticancer strategyNature Reviews Drug Discovery, 2013
- Tumour heterogeneity and cancer cell plasticityNature, 2013
- Selective killing of cancer cells by a small molecule targeting the stress response to ROSNature, 2011
- An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsBlood, 2007
- Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanateCancer Cell, 2006